Mysore Petro Chemicals Posts ₹9.56 Crore Q1 Profit, Aided by Associate
Key highlights
- Mysore Petro Chemicals reported ₹9.56 crore consolidated net profit in Q1 FY27 versus a ₹0.40 crore loss in Q1 FY26.
- Q1 FY27 sales rose 57.58% year-on-year to ₹11.44 crore from ₹7.26 crore.
- Mysore Petro Chemicals reported Q1 FY27 earnings per share of ₹14.52, compared with negative ₹0.60 a year earlier.
- The June 2026 operating profit margin was negative 2.88%, improving from negative 32.92% in June 2025.
powered by IRIS

Mysore Petro Chemicals Limited reported consolidated net profit of ₹9.56 crore for the quarter ended June 2026, compared with a net loss of ₹0.40 crore a year earlier, with the company attributing the sharp increase to its share of profit from an associate.
Know Mysore Petro Chemicals inside out
Results, valuation, peers and who's buying, in one view.
What did Mysore Petro Chemicals report for Q1 FY27?
Mysore Petro Chemicals reported sales of ₹11.44 crore in Q1 FY27, up 57.58% from ₹7.26 crore in the quarter ended June 2025. Consolidated profit after tax was ₹9.56 crore, compared with a ₹0.40 crore loss in the corresponding quarter of the previous year.
The June-quarter result marked a substantial change in reported profitability. The company recorded profit before depreciation and tax of ₹12.81 crore, against a loss of ₹0.06 crore a year earlier. Profit before tax stood at ₹12.73 crore, compared with a ₹0.14 crore loss in Q1 FY26. Its operating profit margin remained negative at 2.88%, though this was an improvement from a negative margin of 32.92% a year earlier.
Mysore Petro Chemicals said the consolidated profit was driven by an associate's share of profit. Its standalone profit after tax rose 140% year-on-year to ₹2.96 crore. This distinction is important because the consolidated result includes the financial contribution from entities accounted for as associates, while standalone profit reflects the company's own operations.
How did the June-quarter result compare with the previous year?
Mysore Petro Chemicals moved from a loss to a consolidated profit, while sales increased by about 58% year-on-year. The reported ₹9.56 crore profit compares with a ₹0.40 crore loss in Q1 FY26, producing a year-on-year improvement of ₹9.96 crore in the bottom line.
The company also reported earnings per share of ₹14.52 for Q1 FY27. This was higher than ₹4.59 in the preceding quarter and compared with negative ₹0.60 in the June 2025 quarter, according to the financial summary provided. Expenses were reported to have declined 50.6% quarter-on-quarter while rising 47.8% year-on-year.
Revenue metrics in the supplied financial summaries use different labels and figures. The quarterly result announcement identifies sales of ₹11.44 crore for June 2026, described as revenue from operations as filed. Another summary cites Q1 FY27 revenue of ₹15.81 crore. The reported sales figure of ₹11.44 crore is used here for the year-on-year comparison because it is accompanied by the detailed quarterly profit-and-loss statement.
What are the key June 2026 financial figures?
The key reported figures show higher sales, a return to consolidated profit and a sizeable contribution outside the company's standalone operations. Operating profitability improved from the same quarter last year but remained below zero based on the reported operating margin.
The gap between the negative operating margin and the reported consolidated net profit underlines the relevance of the associate contribution to the quarter. Investors assessing recurring operating performance may therefore distinguish between the sales and operating-margin trend and the consolidated profit figure.
Got a follow-up? Ask IRIS
What is the company's recent financial background?
Mysore Petro Chemicals manufactures and trades petrochemical products in India and is a public limited listed company incorporated in Karnataka in 1969. For the year ended March 2026, the company reported total operating revenue of ₹52.21 crore and equity capital of ₹6.59 crore.
A separate full-year earnings release reported revenue of ₹52.21 crore for FY26, up 56% from FY25, and net income of ₹0.81 crore, down 94% from the prior year. It reported earnings per share of ₹1.23 for FY26, compared with ₹21.49 in FY25, while the profit margin declined to 1.6% from 42%.
The quarterly recovery follows a volatile period in the company's reported earnings. In the December 2025 quarter, Mysore Petro Chemicals reported a loss per share of ₹2.91, an improvement from a ₹8.29 loss per share in the comparable prior-year quarter. Revenue for that quarter was reported at ₹20.27 crore, while the net loss narrowed to ₹1.91 crore.
Why does the result matter for investors?
The Q1 FY27 result matters because Mysore Petro Chemicals returned to reported consolidated profitability after a loss in the comparable quarter and delivered 57.58% sales growth. The result also shows that the associate's share of profit had a material role in lifting consolidated profit to ₹9.56 crore.
For shareholders, the key issue is the composition of earnings. Standalone profit of ₹2.96 crore was materially below consolidated profit, while the operating margin was still negative. These figures indicate that the improvement in the consolidated bottom line cannot be viewed only through the company's core operating margin.
Mysore Petro Chemicals had earlier announced that it would report Q1 FY27 results on August 10, 2026. The company later closed its trading window from October 1, 2026 ahead of Q2 FY27 results, with the window scheduled to reopen 48 hours after the results are announced to stock exchanges. This places the June-quarter numbers in the context of the company's next scheduled earnings disclosure.
Conclusion
Mysore Petro Chemicals reported a notable shift in its June 2026 quarter, with ₹9.56 crore consolidated net profit against a ₹0.40 crore loss a year earlier and sales up to ₹11.44 crore. However, the company's disclosure that an associate's profit drove the consolidated outcome, alongside a negative operating margin, is central to interpreting the result.
Investors will watch the Q2 FY27 announcement for evidence on sales momentum, operating margins and the extent to which associate income continues to support consolidated profitability. The company has already indicated that its trading window was closed ahead of the results and will reopen 48 hours after the financial disclosure to stock exchanges.


